Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma

Completed

Conditions studied: Lymphoma, Small Intestine Cancer

In brief

RATIONALE: Measuring the number of radiolabeled white blood cells in non-Hodgkin's lymphoma tumors may help doctors predict how well patients will respond to treatment, and may help the study of cancer in the future. PURPOSE: This study is measuring radiolabeled white blood cells in patients with non-Hodgkin's lymphoma.

Key facts

Study ID

NCT00897923

Run by

Mayo Clinic

People needed

17

Starts

2003-09-01

Expected to finish

2012-02-10

Last updated by the study team

2017-03-22

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.